Andrea Cox

Andrea Cox is a Professor of Medicine and Oncology at The Johns Hopkins University School of Medicine in Baltimore.  She earned her Ph.D. studying T cell immunology at The University of Virginia. She subsequently completed an M.D. and then Internal Medicine and Infectious Disease training at Johns Hopkins. Her laboratory investigates human immune responses to SARS-CoV-2, hepatitis C virus (HCV), hepatitis B virus (HBV), and HIV, including mechanisms through which these infections stimulate and evade immune responses, and in HCV vaccine development. She is also the co-director of the Johns Hopkins SARS-CoV-2 Pathogenesis and Immunity Center with Sabra Klein. As a member of the Viral Hepatitis Center in the Division of Infectious Diseases, she specializes in the treatment of patients with viruses including hepatitis virus infections, SAR-CoV-2, and HIV. She was the principal investigator on the first prophylactic HCV vaccine trial ever implemented in an at-risk population, and is the lead immunologist on an ACTG trial of HBV vaccines in HIV infected patients.